{"id":8737,"date":"2025-09-25T10:26:45","date_gmt":"2025-09-25T07:26:45","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8737"},"modified":"2025-09-25T10:26:45","modified_gmt":"2025-09-25T07:26:45","slug":"the-2025-emergency-approach-to-acute-pulmonary-edema","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/the-2025-emergency-approach-to-acute-pulmonary-edema\/","title":{"rendered":"The 2025 Emergency Approach to Acute Pulmonary Edema"},"content":{"rendered":"
The 2025 Emergency Approach to Acute Pulmonary Edema<\/div>\n
<\/div>\n
Sources:<\/div>\n
\u2022 Cureus. Published September 14, 2025.<\/span><\/div>\n
\u2022 J Clin Med. Comparison of Guidelines for Acute Heart Failure. Published 2025.<\/span><\/div>\n
<\/div>\n
1. Definition and Urgency<\/div>\n
\u2022 Acute pulmonary edema (APE) is a hyper-acute emergency presentation of alveolar flooding.<\/span><\/div>\n
\u2022 The most common cause is cardiogenic due to acute left ventricular failure, often triggered by acute coronary syndromes (ACS) or hypertensive crisis.<\/span><\/div>\n
\u2022 Patients may present with severe dyspnea, hypoxemia, agitation, and diffuse crackles.<\/span><\/div>\n
\u2022 Blood pressure may be high, normal, or low, and the management must adapt accordingly.<\/span><\/div>\n
<\/div>\n
2. Causes of Acute Pulmonary Edema<\/div>\n
\u2022 Cardiogenic (most common):<\/span><\/div>\n
\u2022 Acute coronary syndromes (STEMI\/NSTEMI).<\/span><\/div>\n
\u2022 Hypertensive emergency (SCAPE).<\/span><\/div>\n
\u2022 Acute valvular regurgitation (e.g., mitral, aortic).<\/span><\/div>\n
\u2022 Arrhythmias (AF with rapid ventricular response, VT).<\/span><\/div>\n
\u2022 Acute decompensated chronic heart failure.<\/span><\/div>\n
\u2022 Non-cardiogenic:<\/span><\/div>\n
\u2022 ARDS, sepsis.<\/span><\/div>\n
\u2022 NPE (Neurogenic Pulmonary Edema): occurs after SAH, ICH, massive ischemic stroke with raised ICP, or seizures.<\/span><\/div>\n
\u2022 Toxins\/drugs (opioids, salicylates, inhaled gases).<\/span><\/div>\n
\u2022 TRALI (transfusion-related acute lung injury).<\/span><\/div>\n
\u2022 HAPE (high-altitude pulmonary edema).<\/span><\/div>\n
\u2022 Post-obstructive pulmonary edema (after relief of acute upper airway obstruction).<\/span><\/div>\n
\u2022 Pancreatitis.<\/span><\/div>\n
\u2022 Renal & Hepatic failure \/ fluid overload:<\/span><\/div>\n
* Renal failure is a frequent contributor (especially ESRD patients on dialysis) \u2192 fluid overload \u2192 APE.<\/div>\n
* Usually classified as exacerbation of HF \/ cardiogenic-like because it is related to volume\/pressure overload.<\/div>\n
<\/div>\n
Cardiogenic causes remain far more common than non-cardiogenic ones, while renal failure with fluid overload is a frequent contributing factor among the latter. In emergency and cardiology wards most cases are cardiogenic, whereas in intensive care units non-cardiogenic causes such as ARDS and sepsis may account for a larger proportion.<\/div>\n
<\/div>\n
3. Initial ED Workup (parallel with stabilization):<\/div>\n
\u2022 12-lead ECG \u2192 detect ischemia, infarction, arrhythmia.<\/span><\/div>\n
\u2022 High-sensitivity Troponin \u2192 confirm\/exclude ACS, prognostic value.<\/span><\/div>\n
\u2022 BNP\/NT-proBNP:<\/span><\/div>\n
\u2022 Elevated in cardiogenic pulmonary edema:<\/span><\/div>\n
* BNP >500 pg\/mL<\/div>\n
* NT-proBNP >1000 pg\/mL<\/div>\n
\u2022 Very low levels (<100) make a cardiac cause unlikely.<\/span><\/div>\n
\u2022 Always interpret in the context of age, renal function, obesity, and comorbidities.<\/span><\/div>\n
\u2022 Chest X-ray and PoCUS \u2192 confirm pulmonary congestion, assess heart and IVC.<\/span><\/div>\n
\u2022 Basic labs \u2192 renal function, electrolytes, ABG if severe hypoxemia.<\/span><\/div>\n
<\/div>\n
4. Immediate Stabilization (Airway and Oxygenation)<\/div>\n
\u2022 NIV (Non-Invasive Ventilation: CPAP\/BiPAP) is first-line if hypoxemic or in respiratory distress.<\/span><\/div>\n
\u2022 Improves oxygenation, reduces preload\/afterload, prevents intubation.<\/span><\/div>\n
\u2022 Initiate immediately unless contraindicated.<\/span><\/div>\n
<\/div>\n
5. Rapid Bedside Assessment<\/div>\n
\u2022 PoCUS (Point-of-Care Ultrasound): portable handheld or laptop-sized ultrasound.<\/span><\/div>\n
\u2022 Lungs: B-lines = pulmonary edema.<\/span><\/div>\n
\u2022 Heart: LV systolic function, valvular status.<\/span><\/div>\n
\u2022 IVC: volume status and venous congestion.<\/span><\/div>\n
\u2022 Complements echocardiography, which remains the gold standard.<\/span><\/div>\n
\u2022 Introduced in the 1990s, widely adopted after 2000; now standard in high-income countries, increasingly available in resource-limited settings.<\/span><\/div>\n
<\/div>\n
\u2022 BNP\/NT-proBNP:<\/span><\/div>\n
\u2022 Diagnostic: BNP >500 pg\/mL or NT-proBNP >1000 pg\/mL suggests cardiogenic cause; <100 excludes it.<\/span><\/div>\n
\u2022 Prognostic: higher levels = worse outcomes.<\/span><\/div>\n
\u2022 Decongestion check: falling levels before discharge support safe transition.<\/span><\/div>\n
<\/div>\n
6. Vasodilator Therapy<\/div>\n
\u2022 Nitroglycerin (IV): cornerstone when blood pressure is elevated.<\/span><\/div>\n
\u2022 Hypertensive APE \/ SCAPE (SBP \u2265160 mmHg):<\/span><\/div>\n
\u2022 Bolus: 600\u20131000 \u00b5g IV over 1\u20132 min.<\/span><\/div>\n
\u2022 Infusion: start 100\u2013200 \u00b5g\/min, titrate up to ~400 \u00b5g\/min if tolerated.<\/span><\/div>\n
\u2022 Normotensive APE (SBP 110\u2013140 mmHg):<\/span><\/div>\n
\u2022 Optional low-dose infusion (20\u201340 \u00b5g\/min) if congestion is significant and BP stable.<\/span><\/div>\n
\u2022 Hypotension (SBP <100 mmHg or shock):<\/span><\/div>\n
\u2022 Avoid nitroglycerin; manage with vasopressors\/inotropes and cautious fluids.<\/span><\/div>\n
<\/div>\n
7. Role of Loop Diuretics<\/div>\n
\u2022 Not first-line in hypertensive flash edema (SCAPE).<\/span><\/div>\n
\u2022 Normotensive APE: IV furosemide is the pharmacologic cornerstone.<\/span><\/div>\n
\u2022 Timing: after stabilization of oxygenation and BP (\u224815\u201330 min).<\/span><\/div>\n
\u2022 Dosing:<\/span><\/div>\n
\u2022 40\u201380 mg IV initially.<\/span><\/div>\n
\u2022 If on chronic diuretics \u2192 1\u20132\u00d7 home dose IV.<\/span><\/div>\n
\u2022 Goal: gradual decongestion and sustained relief of symptoms.<\/span><\/div>\n
<\/div>\n
8. Non-Cardiogenic Pulmonary Edema (NCPE) \u2013 Management<\/div>\n
\u2022 Treat the underlying cause (infection, neurologic insult, altitude, toxins).<\/span><\/div>\n
\u2022 Provide oxygen therapy.<\/span><\/div>\n
\u2022 Use cautious fluids; add vasopressors if indicated.<\/span><\/div>\n
\u2022 Apply lung-protective ventilation if intubated.<\/span><\/div>\n
\u2022 Utilize PoCUS (complements echocardiography in ER) to help differentiate NCPE from cardiogenic forms.<\/span><\/div>\n
<\/div>\n
Key Takeaways (2025 Evidence)<\/div>\n
1. Always rule out ACS with ECG + Troponin.<\/span><\/div>\n
2. NIV + high-dose nitroglycerin = lifesaving in hypertensive APE.<\/span><\/div>\n
3. Loop diuretics = cornerstone in normotensive APE; delayed in SCAPE.<\/span><\/div>\n
4. PoCUS = rapid bedside tool; echo remains gold standard.<\/span><\/div>\n
5. BNP\/NT-proBNP = diagnostic, prognostic, and discharge guidance.<\/span><\/div>\n
6. Avoid nitro in hypotension; support with vasopressors\/inotropes.<\/span><\/div>\n
7. Cardiogenic causes remain far more common; renal failure with fluid overload is a frequent contributor among non-cardiogenic.<\/span><\/div>\n
8. Early, aggressive therapy reduces intubation, ICU stay, and mortality.<\/span><\/div>\n
<\/div>\n
Sources:<\/div>\n
<\/div>\n
https:\/\/www.cureus.com\/articles\/381557<\/div>\n
<\/div>\n
<\/div>\n
https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12112131\/<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

The 2025 Emergency Approach to Acute Pulmonary Edema Sources: \u2022 Cureus. Published September 14, 2025. \u2022 J Clin Med. Comparison of Guidelines for Acute Heart Failure. Published 2025. 1. Definition and Urgency \u2022 Acute pulmonary edema (APE) is a hyper-acute emergency presentation of alveolar flooding. \u2022 The most common cause is cardiogenic due to acute […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8737","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8737"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8737\/revisions"}],"predecessor-version":[{"id":8738,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8737\/revisions\/8738"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}